Close

Ratings by Wells Fargo (Chris M. Carey)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/8/2022 Morphic Therapeutic MORF Maintain Overweight
(N/A)
 
 
  Details
11/8/2022 Immunovant IMVT Maintain Equal Weight
(N/A)
 
 
  Details
11/7/2022 Ascendis Pharma ASND Maintain Overweight
(N/A)
 
 
  Details
9/14/2022 Cabaletta Bio Inc. CABA Maintain Overweight
(N/A)
 
 
  Details
9/6/2022 Apellis Pharmaceuticals APLS Maintain Overweight
(N/A)
 
 
  Details
8/4/2022 Morphic Therapeutic MORF Maintain Overweight
(N/A)
 
 
  Details
8/3/2022 Hydrofoam HYFM Maintain Equal Weight
(N/A)
 
 
  Details
6/28/2022 Kezer Life Sciences KZR Maintain Overweight
(N/A)
 
 
  Details
6/22/2022 Hydrofoam HYFM Maintain Equal Weight
(N/A)
 
 
  Details
5/13/2022 Prometheus Biosciences Inc RXDX Maintain Overweight
(N/A)
 
 
  Details
5/13/2022 Kezer Life Sciences KZR Maintain Overweight
(N/A)
 
 
  Details
5/12/2022 Ascendis Pharma ASND Maintain Overweight
(N/A)
 
 
  Details
5/5/2022 Morphic Therapeutic MORF Maintain Overweight
(N/A)
 
 
  Details
3/23/2022 Horizon Therapeutics HZNP Maintain Overweight
(N/A)
 
 
  Details
3/10/2022 Prometheus Biosciences Inc RXDX Maintain Overweight
(N/A)
 
 
  Details
3/3/2022 Ascendis Pharma ASND Maintain Overweight
(N/A)
 
 
  Details
3/1/2022 Hydrofoam HYFM Maintain Equal Weight
(N/A)
 
 
  Details
3/1/2022 GrowGeneration GRWG Maintain Equal Weight
(N/A)
 
 
  Details
1/13/2022 GrowGeneration GRWG Maintain Equal Weight
(N/A)
 
 
  Details
12/8/2021 Rhythm Pharmaceuticals RYTM New Coverage Overweight
(N/A)
9.26
(25.01)
170.09% Details
12/8/2021 Prometheus Biosciences Inc RXDX New Coverage Overweight
(N/A)
29.92
(44.32)
48.13% Details
12/8/2021 Morphic Therapeutic MORF New Coverage Overweight
(N/A)
47.72
(27.91)
-41.51% Details
12/8/2021 Immunovant IMVT New Coverage Equal Weight
(N/A)
7.65
(13.36)
74.64% Details
12/8/2021 Horizon Therapeutics HZNP New Coverage Overweight
(N/A)
98.56
(78.86)
-19.99% Details
12/8/2021 Cabaletta Bio Inc. CABA New Coverage Overweight
(N/A)
10.68
(3.69)
-65.45% Details
12/8/2021 Ascendis Pharma ASND New Coverage Overweight
(N/A)
136.64
(117.40)
-14.08% Details
12/8/2021 Arena Pharma ARNA New Coverage Overweight
(N/A)
50.07
(99.98)
99.68% Details
12/8/2021 Kezer Life Sciences KZR New Coverage Overweight
(N/A)
13.44
(7.51)
-44.12% Details
12/8/2021 Apellis Pharmaceuticals APLS New Coverage Overweight
(N/A)
40.03
(50.56)
26.31% Details
12/7/2021 GrowGeneration GRWG New Coverage Equal Weight
(N/A)
15.17
(5.73)
-62.23% Details
12/7/2021 Hydrofoam HYFM New Coverage Equal Weight
(N/A)
29.15
(2.51)
-91.39% Details